Distinct ventral and dorsal hippocampus AP5 anxiolytic effects revealed in the elevated plus-maze task in rats

Neurobiology of Learning and Memory

Volumn 88, Issue 2, 2007, Pages 177-185

  Nascimento Häckl, Luciane Pereira ^a   Carobrez, Antônio Pádua ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Anxiety; Dorsal hippocampus; Elevated plus maze; Learning; NMDA receptors; Rat; Ventral hippocampus

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN REGION; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; LEARNING; MALE; MAZE TEST; MEMORY; NONHUMAN; RAT; RISK ASSESSMENT; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY; MICROINJECTIONS; PENTANOIC ACIDS; PHOSPHONIC ACIDS; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 34547659926     PISSN: 10747427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nlm.2007.04.007     Document Type: Article

References (63)

1. 2c agonists into ventral but not dorsal hippocampus. Behavioural Pharmacology 15 (2004) 37-43
2. Amaral D.G., and Witter M.P. The three-dimensional organization of the hippocampal formation: A review of anatomical data. Neuroscience 31 (1989) 571-591
3. Amaral D.G., and Witter M.P. (1995), Academic Press, San Diego
4. Andreatini R., Vital M.A.B.F., and Santos G.L. The reinstatement of conflict reverses the one-trial tolerance to diazepam on elevated plus-maze. European Neuropsychopharmacology 13 suppl. 4 (2003) S378-S379
5. Bannerman D.M., Deacon R.M., Offen S., Friswell J., Grubb M., and Rawlins J.N. Double dissociation of function within the hippocampus: Spatial memory and hyponeophagia. Behavioral Neuroscience 116 (2002) 884-901
6. Bannerman D.M., Rawlins J.N., and Good M.A. The drugs don't work-or do they? Pharmacological and transgenic studies of the contribution of NMDA and GluR-A-containing AMPA receptors to hippocampal-dependent memory. Psychopharmacology 188 (2006) 552-566
7. Bannerman D.M., Rawlins J.N., McHugh S.B., Deacon R.M., Yee B.K., Bast T., et al. Regional dissociations within the hippocampus-memory and anxiety. Neuroscience and Biobehavioral Reviews 28 (2004) 273-283
8. Bergink V., Megen H.G., and Westenberg H.G. Glutamate and anxiety. European Neuropsychopharmacology 14 (2004) 175-183
9. Bertoglio L.J., Anzini C., Lino-de-Oliveira C., and Carobrez A.P. Enhanced dorsolateral periaqueductal gray activity counteracts the anxiolytic response on midazolam on the elevated plus-maze Trial 2 in rats. Behavioural Brain Research 162 (2005) 99-107
10. Bertoglio L.J., and Carobrez A.P. Scopolamine given pre-Trial 1 prevents the one-trial tolerance phenomenon in the elevated plus-maze Trial 2. Behavioural Pharmacology 15 1 (2004) 45-54
11. Bertoglio L.J., and Carobrez A.P. Previous maze experience required to increase open arm avoidance in rats submitted to the elevated plus-maze model of anxiety. Behavioural Brain Review 108 (2000) 197-203
12. Bertoglio L.J., and Carobrez A.P. Anxiolytic effects of ethanol and phenobarbital are abolished in test-experienced rats submitted to the elevated plus-maze. Pharmacology, Biochemistry and Behavior 73 (2002) 963-969
13. Bertoglio L.J., and Carobrez A.P. Behavioral profile of rats submitted to session 1-session 2 in the elevated plus-maze during diurnal/nocturnal phases and under different illumination conditions. Behavioural Brain Research 132 (2002) 135-143
14. Bertoglio L.J., and Carobrez A.P. Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze Trial 2 in rats. Psychopharmacology 170 (2003) 335-342
15. Bertoglio L.J., Joca S.R.L., and Guimarães F.S. Further evidence that anxiety and memory are regionally dissociated within the hippocampus. Behavioural Brain Research 175 (2006) 183-188
16. Bliss T.V.P., and Collingridge G.L. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 361 (1993) 31-39
17. Carobrez A.P. Glutamatergic neurotransmission as molecular target in anxiety. Revista Brasileira de Psiquiatria 25 Suppl. 2 (2003) 52-58
18. Carobrez A.P., and Bertoglio L.J. Ethological and temporal analyses of anxiety-like behavior: The elevated plus-maze model 20 years on. Neuroscience and Biobehavioral Reviews 29 (2005) 1193-1205
19. Carobrez A.P., Teixeira K.V., and Graeff F.G. Modulation of defensive behavior by periaqueductal gray NMDA/glycine-B receptor. Neuroscience and Biobehavioral Reviews 25 (2001) 697-709
20. Cruz-Morales S.E., Santos N.R., and Brandão M.L. One-trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat. Pharmacology, Biochemistry and Behavior 72 (2002) 973-978
21. Dal-Cól M.L.C., Orlandi-Pereira L., Rosa V.P., Calixto A.V., Carobrez A.P., and Faria M.S. Lack of midazolam-induced anxiolysis in the plus-maze Trial 2 is dependent on the length of Trial 1. Pharmacology, Biochemistry and Behavior 74 2 (2003) 395-400
22. 1a receptor and NMDA receptor antagonists in the social interaction test and the elevated plus-maze. European Journal of Pharmacology 169 (1989) 1-10
23. Espejo E.F. Effects of weekly or daily exposure to the elevated-plus-maze in male mice. Behavioural Brain Research 87 (1997) 233-238
24. Fanselow M.S., Kim J.J., Yipp P., and DeOca B. Differential effects of N-methyl-d-aspartate antagonist dl-2-amino-5-phosphonovalerate on acquisition of fear of auditory and contextual cues. Behavioral Neuroscience 108 (1994) 235-240
25. File S.E., Zangrossi Jr. H., Viana M., and Graeff F.G. Trial 2 in the elevated plus-maze: A different form of fear?. Psychopharmacology 111 (1993) 491-494
26. File S.E. The interplay of learning and anxiety in the elevated plus-maze. Behavioural Brain Research 58 (1993) 199-202
27. File S.E., Gonzalez L.E., and Gallant R. Role of the basolateral nucleus of the amygdala in the formation of a phobia. Neuropsychopharmacology 19 (1998) 397-405
28. File S.E., Gonzalez L.E., and Gallant R. Role of the dorsomedial hypothalamus in mediating the response to benzodiazepines on trial 2 in the elevated plus-maze test of anxiety. Neuropsychopharmacology 21 (1999) 312-320
29. File S.E., Mabbutt P.S., and Hitchott P.K. Characterization of the phenomenon of 'one-trial tolerance' to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. Psychopharmacology 102 (1990) 98-101
30. Gray J.A., and McNaughton N. The neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal system. 2nd ed. (2000), Oxford University Press, New York
31. Griebel G., Moreau J.L., Jenck F., Martin J.R., and Misslin R. Some critical determinants of the behavior of rats in the elevated plus-maze. Behavioural Processes 29 (1993) 37-48
32. Guimaraes F.S., Carobrez A.P., De Aguiar J.C., and Graeff F.G. Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey. Psychopharmacology 103 (1991) 91-94
33. Handley S.L., and Mithani S. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn Schmiedebergs Archives of Pharmacology 327 (1984) 1-5
34. Holden C. Psychiatric drugs excited by glutamate (2003), Science
35. Izquierdo I., Da Cunha C., Rosat R., Jerusalinsky D., Ferreira M.B.C., and Medina J.H. Neurotransmitter receptors involved in post-training memory processing by the amygdala, medial septum and hippocampus of the rat. Behavioral and Neural Biology 58 (1992) 16-26
36. Jacobsen L., and Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocrine Review 12 (1991) 118-134
37. Javitt D.C. Glutamate receptors as therapeutic targets. Molecular Psychiatry 9 (2004) 984-997
38. Jay T.M., and Witter M.P. Distribution of hippocampal CA1 and subicular efferents in the prefrontal cortex of the rat studied by means of anterograde transport of Phaseolus vulgaris-leucoagglutinin. Journal of Comparative Neurology 313 (1991) 574-586
39. Kjelstrup K.G., Tuvnes F.A., Steffenach H.A., Murison R., Moser E.I., and Moser M.B. Reduced fear expression after lesions of the ventral hippocampus. Proceedings of the National Academy of Sciences 99 (2002) 10825-10830
40. Leonardo E.D., Richardson-Jones J.W., Sibille E., Kottman A., and Hen R. Molecular heterogeneity along the dorsal-ventral axis of the murine hippocampal CA1 field: A microarray analysis of gene expression. Neuroscience 137 (2006) 177-186
41. Lister R. Ethologically based animal models of anxiety disorders. Pharmacology Therapeutic 46 (1990) 321-340
42. Maren S., and Holt W.G. Hippocampus and Pavlovian fear conditioning in rats: Muscimol infusions into the ventral, but not dorsal, hippocampus impair the acquisition of conditional freezing to an auditory conditional stimulus. Behavioral Neuroscience 118 (2004) 97-110
43. McHugh S.B., Deacon R.M.J., Rawlins J.N.P., and Bannerman D.M. Amygdala and ventral hippocampus contribute differentially to mechanisms of fear and anxiety. Behavioral Neuroscience 118 (2004) 63-78
44. Morris R.G.M., and Davis M. The role of NMDA receptors in learning and memory. In: Collingridge G.L., and Watkins J.C. (Eds). The NMDA receptor (1994), Oxford University Press, Oxford 340-375
45. Moser M.B., and Moser E.I. Functional differentiation in the hippocampus. Hippocampus 8 (1998) 608-619
46. Nunes-de-Souza L.R., Canto-de-Souza A., and Rodgers R.J. Effects of intra-hippocampal infusion of WAY-100635 on plus-maze behavior in mice: Influence of site of injection and prior test experience. Brain Research 927 (2002) 87-96
47. Pandis C., Sotiriou E., Kouvaras E., Asprodini E., Papatheodoropoulos C., and Angelatou F. Differential expression of NMDA and AMPA receptor subunits in rat dorsal and ventral hippocampus. Neuroscience 140 (2006) 163-175
48. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 4th ed. (1998), Academic Press, New York
49. Pentkowski N.S., Blanchard D.C., Lever C., Litvin Y., and Blanchard R.J. Effects of lesions to the dorsal and ventral hippocampus on defensive behaviors in rats. European Journal of Neuroscience 23 (2006) 2185-2196
50. Pereira J.K.D., Vieira R.J., Konishi C.T., Ribeiro R.A., and Frussa-Filho R. The phenomenon of "one trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze is abolished by the introduction of a motivational conflict situation. Life Sciences 65 (1999) 101-107
51. Petrovich G.D., Canteras N.S., and Swanson L.W. Combinatorial amygdalar inputs to hippocampal domains hypothalamic behavior systems. Brain Research Reviews 38 (2001) 247-289
52. Pitkanen A., Pikkarainen M., Nurminen N., and Ylinen A. Reciprocal connections between the amygdala and the hippocampal formation, perirhinal cortex and postrhinal cortex in rat. A review. Annuals of the New York Academy of Sciences 911 (2000) 369-391
53. Richmond M.A., Yee B.K., Pouzet B., Veenman L., Rawlins J.N.P., Feldon J., et al. Dissociating context and space within the hippocampus: Effects of complete, dorsal and ventral excitotoxic hippocampus lesions on conditioned freezing and spatial learning. Behavioral Neuroscience 113 (1999) 1189-1203
54. Risold P.Y., and Swanson L.W. Structural evidence for functional domains in the rat hippocampus (1996), Science
55. Rodgers R.J., and Shepherd J.K. Influence of prior maze experience on behavior and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice. Psychopharmacology 113 (1993) 237-242
56. Roesler R., Vianna M., Sant' Anna M.K., Kuyven C.R., Kruel A.V., Quevedo J., et al. Intrahippocampal infusion of the NMDA receptor antagonist AP5 impairs retention of an inhibitory avoidance task: protection from impairment by pretraining or preexposure to the task apparatus. Neurobiology of Learning and Memory 69 (1998) 87-91
57. a receptor subunits in rat dorsal and ventral hippocampus. Journal of Neuroscience Research 82 (2005) 690-700
58. Stewart L.S., and McKay B.E. Acquisition deficit and time-dependent retrograde amnesia for contextual fear conditioning in agmatine-treated rats. Behavioural Pharmacology 11 (2000) 93-100
59. Swanson L.W., and Cowan W.M. An autoradiographic study of the organization of the efferent connections of the hippocampal formation in the rat. Journal of Comparative Neurology 172 (1977) 49-84
60. Treit D., Menard J., and Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacology, Biochemistry and Behavior 44 (1993) 463-469
61. Trivedi M.A., and Coover G.D. Lesions of the ventral hippocampus, but not the dorsal hippocampus, impair conditioned fear expression and inhibitory avoidance on the elevated T-maze. Neurobiology of Learning and Memory 81 (2004) 172-184
62. Verwer R.W., Meijer R.J., Van Uum H.F., and Witter M.P. Collateral projections from the rat hippocampal formation to the lateral and medial prefrontal cortex. Hippocampus 7 (1997) 397-402
63. Witter M.P., Naber P.A., Van Haeften T., Machielsen W.C., Rombouts S.A., Bankhof F., et al. Cortico-hippocampal communication by way of parallel parahippocampal-subicular pathways. Hippocampus 10 (2000) 398-410